Royce Associates LP Invests 8.34 Million in Bioventus Inc. - MarketBeat
| BVS Stock | USD 11.71 0.20 1.74% |
Slightly above 55% of Bioventus' private investors are presently thinking to get in. The analysis of overall sentiment of trading Bioventus stock suggests that some investors are interested at this time. Bioventus' investing sentiment can be driven by a variety of factors including economic data, Bioventus' earnings reports, geopolitical events, and overall market trends.
Bioventus |
Royce Associates LP Invests 8.34 Million in Bioventus Inc. MarketBeat
Read at news.google.com
 |
Bioventus Fundamental Analysis
We analyze Bioventus' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bioventus using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bioventus based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Shares Outstanding
Shares Outstanding Comparative Analysis
Bioventus is currently under evaluation in shares outstanding category among its peers. Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Bioventus Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Bioventus stock to make a market-neutral strategy. Peer analysis of Bioventus could also be used in its relative valuation, which is a method of valuing Bioventus by comparing valuation metrics with similar companies.
Peers
Bioventus Related Equities
| NAOV | NanoVibronix | 9.23 | ||||
| VVOS | Vivos Therapeutics | 8.47 | ||||
| TIVC | Tivic Health | 4.17 | ||||
| RPID | Rapid Micro | 3.60 | ||||
| HSCS | Heart Test | 1.91 | ||||
| BBLG | Bone Biologics | 1.63 | ||||
| BJDX | Bluejay Diagnostics | 0.57 | ||||
| NUWE | Nuwellis | 2.42 |
Additional Tools for Bioventus Stock Analysis
When running Bioventus' price analysis, check to measure Bioventus' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bioventus is operating at the current time. Most of Bioventus' value examination focuses on studying past and present price action to predict the probability of Bioventus' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bioventus' price. Additionally, you may evaluate how the addition of Bioventus to your portfolios can decrease your overall portfolio volatility.